Accuracy of diabetic retinopathy screening not affected by mydriasis

Article

An investigation published in the Archives of Ophthalmology has indicated that the accuracy of screening for diabetic retinopathy (DR) is affected by the qualifications of retinal photographers but not by mydriasis.

An investigation published in the Archives of Ophthalmology has indicated that the accuracy of screening for diabetic retinopathy (DR) is affected by the qualifications of retinal photographers but not by mydriasis.

The team, led by Dr Peter Bragge of the National Trauma Research Institute, Melbourne, Australia, researched how mydriasis and the medical qualifications of photographers who take retinal photographs influence the screening accuracy for DR.

The researchers analysed studies that measured the sensitivity and specificity of tests designed to detect any DR, sight-threatening DR or macular oedema. The effects of variations in mydriatic status and in the medical qualifications of photographers on sensitivity and specificity were looked at through random-effects logistic regression.

It was found that the only group of tests that were consistent enough for meta analysis was the "any DR" category. In these studies no significant influence to sensitivity or specificity was found when the mydriatic status varied. This was also true for variations in medical qualifications of photographers. However, the specificity of detection of any DR was higher in screening methods using a photographer with specialist medical or eye qualifications.

It was concluded that outreach screening is a successful alternative to on-site specialist examination. The procedure is ideal for screening high-risk diabetic retinopathy patients in rural areas or areas with limited screening facilities. However, the study was confined to the presence or absence of DR and future work should use consistent DR classification schemes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.